
<tr>
  <td width="600" style="width: 600px">
    <table width="600" cellpadding="0" cellspacing="0" border="0" valign="top" style="width: 600px;min-width: 600px; vertical-align: middle; background-color: transparent; xxxxxline-height: 18px;">
      <tr>
        <td width="35" style="width: 35px;"></td>
        <td width="530" style="width: 530px; color: #636363; font-family: Arial, sans-serif; font-weight: bold; font-size: 18px;">
          Tresiba<sup style="font-size:0.6em; line-height:0; vertical-align:5px;-webkit-text-size-adjust:none;">&reg;</sup> offers lower out-of-pocket costs than Levemir<sup style="font-size:0.6em; line-height:0; vertical-align:5px;-webkit-text-size-adjust:none;">&reg;</sup>
        </td>
        <td width="35" style="width: 35px;"></td>
      </tr>
    </table>
    <table width="600" cellpadding="0" cellspacing="0" border="0" valign="top" style="width: 600px;min-width: 600px; vertical-align: middle; background-color: transparent; line-height: 18px;">
      <tr>
        <td width="180" valign="top" style="width: 180px; line-height: 0px; padding-top: 10px; vertical-align: top;">
          <img src="https://cdnae1.vod309.com/4abc42fa-0fdf-4c78-8704-da625c7d5356/0000000/000000/001/154/8/2/assetFiles/images/images/divider.png" style="display: block;" />
        </td>
      </tr>
    </table>
    <table width="600" cellpadding="0" cellspacing="0" border="0" valign="top" style="width: 600px;min-width: 600px; vertical-align: middle; background-color: transparent;">
      <tr>
        <td width="35" style="width: 35px;"></td>
        <td width="530" style="width: 530px; padding-top: 15px; padding-bottom: 15px; color: #434343; font-family: Arial, sans-serif; font-size: 14px; line-height: 18px;">
          Novo Nordisk has the best formulary coverage in the basal category. Of Novo Nordiskâ€™s basal insulins, Tresiba<sup style="font-size:0.7em; line-height:0; vertical-align:4px;-webkit-text-size-adjust:none;">&reg;</sup> has 83% national formulary coverage (Commercial and Medicare Part D combined), and is covered nationwide on the majority of Medicare Part D plans.(1,a,b,c) Eligible patients <span style="font-weight: bold">pay as low as $5 for Tresiba</span><sup style="font-size:0.7em; line-height:0; vertical-align:4px;-webkit-text-size-adjust:none;">&reg;</sup> vs $45 for Levemir<sup style="font-size:0.7em; line-height:0; vertical-align:4px;-webkit-text-size-adjust:none;">&reg;</sup>.(d)
        </td>
        <td width="35" style="width: 35px;"></td>
      </tr>
      <tr>
        <td width="35" style="width: 35px;"></td>
        <td width="206" style="width: 206px; line-height: 0px;">
          <a href="https://www.tresibapro.com/savings-and-coverage/coverage.html#/?utm_source=veeva_closerlook&utm_medium=email&utm_content=Tresiba_Levemir_Conversion&utm_campaign=tresiba%202018_levconv" target="_blank" style="border: none; text-decoration: none; display: block;">
            <img src="https://cdnae1.vod309.com/4abc42fa-0fdf-4c78-8704-da625c7d5356/0000000/000000/001/154/8/2/assetFiles/images/images/button-coverage.png" alt="Check your local coverage" style="display: block;" />
          </a>
        </td>
        <td width="35" style="width: 35px;"></td>
      </tr>
      <tr>
        <td width="35" style="width: 35px;"></td>
        <td width="530" style="width: 530px; padding-top: 20px; padding-bottom: 3px; color: #434343; font-family: Arial, sans-serif; font-size: 14px; line-height: 18px;">
          (a)Formulary status subject to change. This information should not be used to make efficacy or safety comparisons between or among mentioned products.
        </td>
        <td width="35" style="width: 35px;"></td>
      </tr>
      <tr>
        <td width="35" style="width: 35px;"></td>
        <td width="530" style="width: 530px; padding-top: 0px; padding-bottom: 3px; color: #434343; font-family: Arial, sans-serif; font-size: 14px; line-height: 18px;">
          (b)Formulary data are provided by Fingertip Formulary<sup style="font-size:0.7em; line-height:0; vertical-align:4px;-webkit-text-size-adjust:none;">&reg;</sup> and are current as of October&nbsp;2018.
        </td>
        <td width="35" style="width: 35px;"></td>
      </tr>
      <tr>
        <td width="35" style="width: 35px;"></td>
        <td width="530" style="width: 530px; padding-top: 0px; padding-bottom: 3px; color: #434343; font-family: Arial, sans-serif; font-size: 14px; line-height: 18px;">
          (c)Medicare Part D data are on file with Novo Nordisk and are current as of October 2018. Expiration date: December 31, 2019.
        </td>
        <td width="35" style="width: 35px;"></td>
      </tr>
      <tr>
        <td width="35" style="width: 35px;"></td>
        <td width="530" style="width: 530px; padding-top: 0px; padding-bottom: 3px; color: #434343; font-family: Arial, sans-serif; font-size: 14px; line-height: 18px;">
          (d)Per 30-day supply for up to 24 months. Maximum savings of $150 per <span style="white-space:nowrap;">30-day supply.</span> <a href="https://www.novocare.com/eligibility/diabetes-savings-card.html?utm_source=veeva_closerlook&utm_medium=email&utm_content=Tresiba_Levemir_Conversion&utm_campaign=tresiba%202018_levconv" target="_blank" style="text-decoration: underline; color: #000;">Eligibility and other restrictions apply.</a>
        </td>
        <td width="35" style="width: 35px;"></td>
      </tr>
    </table>
  </td>
</tr>